Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Change In Receivables : $-9.71 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Change In Receivables?

Skystar Bio-Pharmaceutical Co's change in receivables for the quarter that ended in Sep. 2014 was $-17.54 Mil. It means Skystar Bio-Pharmaceutical Co's Accounts Receivable increased by $17.54 Mil from Jun. 2014 to Sep. 2014 .

Skystar Bio-Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2013 was $-1.02 Mil. It means Skystar Bio-Pharmaceutical Co's Accounts Receivable increased by $1.02 Mil from Dec. 2012 to Dec. 2013 .

Skystar Bio-Pharmaceutical Co's Accounts Receivable for the quarter that ended in Sep. 2014 was $35.35 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Skystar Bio-Pharmaceutical Co's Days Sales Outstanding for the three months ended in Sep. 2014 was 175.74.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Skystar Bio-Pharmaceutical Co's liquidation value for the three months ended in Sep. 2014 was $4.08 Mil.

Skystar Bio-Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Change In Receivables Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Change In Receivables

Get a 7-Day Free Trial

-2.66

-1.16

1.66

-6.39

-1.02

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Change In Receivables	Get a 7-Day Free Trial															-15.69	16.67	-2.13	-6.71	-17.54

Skystar Bio-Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.71 Mil.

Skystar Bio-Pharmaceutical Co (GREY:SKBI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Skystar Bio-Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2014 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	35.347	/	18.353	*	91
=	175.74

2. In Ben Graham's calculation of liquidation value, Skystar Bio-Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Skystar Bio-Pharmaceutical Co's liquidation value for the quarter that ended in Sep. 2014 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	15.122	-	49.104	+	0.75 * 35.347	+	0.5 * 23.108
=	4.08

Skystar Bio-Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines